Phosphatidylinositol 3-kinase related kinases

Current Opinion in Immunology

Volumn 8, Issue 3, 1996, Pages 412-418

  Abraham, Robert T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE;

CANCER; CELL CYCLE; DNA RECOMBINATION; DNA REPAIR; ENZYME ANALYSIS; EVOLUTION; FLY; IMMUNE DEFICIENCY; MAMMAL CELL; NONHUMAN; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION; YEAST;

EID: 0030175487     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80132-4     Document Type: Article

References (69)

1. Panayotou G, Waterfield MD. Phosphatidyl-inositol 3-kinase: a key enzyme in diverse signalling processes. Trends Cell Biol. 2:1992;358-360.
2. Divecha N, Irvine RF. Phospholipid signaling. Cell. 80:1995;269-278.
3. Keith CT, Schreiber SL. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. of special interest Science. 270:1995;50-51 This short review describes the phylogenetic relationship between the newly discovered family of PI3K homologs and the conventional phosphoinositide kinases. The authors also provide a brief overview of the known functions of the high-molecular-mass PI3K homologs.
4. Zakian VA. ATM-related genes: what do they tell us about functions of the human gene? of special interest Cell. 82:1995;684-687 This review focuses on the striking functional convergence of the PI3K homologs on cellular processes related to the maintenance of genomic integrity. The emphasis in this article is on the application of knowledge gained from studies of ATM-related genes expressed in yeast, flies and mice to our understanding of the defects associated with loss of ATM function in humans suffering from AT.
5. Hunter T. When is a lipid kinase not a lipid kinase? When it is a protein kinase. of special interest Cell. 83:1995;1-4 This review provides a succinct overview of the sequence motifs that distinguish the PI3K-related and conventional protein kinase catalytic domains. The author also supplies some insightful speculations with regard to the predicted substrate specificities (protein or phospholipid) of the high-molecular-mass PI3K homologs.
6. Stack JH, Emr SD. Vps34p required for yeast vacuolar protein sorting is a multiple specificity kinase that exhibits both protein kinase and phosphatidylinositol-specific PI 3-kinase activities. J Biol Chem. 269:1994;31552-31562.
7. Stephens L, Cooke FT, Walters R, Jackson T, Volinia S, Gout I, Waterfield MD, Hawkins PT. Characterization of a phosphatidylinositol-specific phospholnositide 3-kinase from mammalian cells. Curr Biol. 4:1994;203-214.
8. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, et al. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13:1994;522-533.
9. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell. 71:1992;543-546.
10. Murray A, Hunt T. Checkpoints and feedback controls. The Cell Cycle. 1993;135-152 WH Freeman and Co, New York.
11. Weinert TA, Kiser GL, Hartwell LH. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 8:1994;652-665.
12. Kato R, Ogawa H. An essential gene, ESR1, is required for mitotic cell growth, DNA repair and mitotic recombination in Saccharomyces cerevisiae. of outstanding interest Nucleic Acids Res. 22:1994;3108-3112 See annotation [13].
13. 2-M phase in S. cerevisiae. Mec1p is a homolog of the human ATM protein, which is mutated in AT. Like AT cells, yeast cells with mutations in MEC1 perform damage-resistant DNA synthesis, and incur higher rates of mutation and cytotoxicity following exposure to ionizing radiation and other genotoxic agents.
14. of outstanding interest Seaton BL, Yucel J, Sunnerhagen P, Subramani S. Isolation and characterization of Schizosaccharomyces pombe rad 3 gene, involved in the DNA damage and DNA synthesis checkpoints. Gene. 119:1992;83-89.
15. + gene of Schizosaccharomyces pombe is involved in multiple checkpoint functions and in DNA repair. Proc Natl Acad Sci USA. 82:1992;4952-4956.
16. Hari KL, Santerre A, Sekelsky JJ, McKim KS, Boyd JB, Hawley RS. The mei-41 gene of D. melanogaster is a structural and functional homolog of the human ataxia telanglectasia gene. of outstanding interest Cell. 82:1995;815-821 The Drosophila melanogaster-gene mei-41 is cloned and is shown to contain a carboxy-terminal catalytic domain bearing a significant similarity to that of the p110 subunit of mammalian PI3K. Neuroblasts from mei-41 mutant flies display intrinsic chromosomal instability and extreme hypersensitivity to ionizing radiation. The authors report that the mei-41 protein is a functional homolog of the human ATM protein.
17. Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B, Petes TD. TEL1, a gene involved in controlling telomere length is S. cerevisiae, is homologous to the human ataxia telanglectasia gene. of outstanding interest Cell. 82:1995;823-829 The authors report the isolation of a cDNA encoding the entire open reading frame of the S. cerevisiae TEL1 gene. The deduced amino acid sequence indicates that Tel1p is a member of the family of PI3K-related kinases, and the closest known homolog of the human ATM protein. Interestingly, mutations in TEL1, but not in MEC1, TOR1 or TOR2, result in telomere shortening in yeast. Thus, Tel1p apparently executes a specialized function related to telomere metabolism in these cells.
18. Morrow DM, Tagle DA, Shiloh Y, Collins FS, Hieter P. Tel1, an S. cerevisiae homolog of the human gene mutated in ataxia telanglectasia, is functionally related to the yeast checkpoint gene MEC1. of outstanding interest Cell. 82:1995;831-840 This paper demonstrates that, in addition to its specialized function is telomere maintenance [17], Tel1p displays functional overlap with Mec1p. Yeast cells bearing mutations in both TEL1 and MEC1 display a synergistic increase in their sensitivity to ionizing radiation. In addition, mec1/tel1 double mutants acquire a hypersensitivity to radiomimetic drugs not demonstrated by mec1 or tel1 single mutants. The phenotype of mec1/tel1 double mutants is highly similar to that of human AT cells, suggesting that the functions of ATM may be divided between two PI3K homologs in S. cerevisiae.
19. Sanchez Y, Desany BA, Jones WJ, Liu Q, Wang B, Elledge SJ. Regulation of RAD53 by the ATM-like kinases MEC1 and TEL1 in yeast cell cycle checkpoint pathways. of outstanding interest Science. 271:1996;357-360 This report shows that Mec1p and Tec1p co-operatively regulate Rad53p, a protein kinase involved in DNA replication and DNA damage checkpoints in S. cerevisiae. Given the phenotypic similarity of yeast mec2/tel1 double mutants in yeast to human AT cells, these results suggest that the PI3K homolog, ATM, regulates a Rad53p-like kinase in response to DNA damage in mammalian cells.
20. Counter CM, Avilion AA, LeFeuve CE, Stewart NG, Greider CW, Harley CB, Bachetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
21. Jackson SP, Jeggo PA. DNA double-strand break repair and V(D)J recombination-involvement of DNA-PK. of outstanding interest Trends Biochem Sci. 20:1995;412-415 This review summarizes the roles of DNA-PK in the cellular response to DNA double-strand breaks occurring during cellular exposure to ionizing radiation or during V(D)J recombination in lymphoid cells.
22. Yaneva M, Ochs R, McRorie DK, Zweig S, Busch H. Purification of an 86-70 kd nuclear DNA-associated protein complex. Biochim Biophys Acta. 841:1985;22-29.
23. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by antibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest. 68:1981;611-620.
24. Mimori T, Hardin JA, Steitz JA. Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem. 261:1986;2274-2278.
25. Mimori T, Hardin JA. Mechanism of interaction between Ku protein and DNA. J Biol Chem. 261:1986;10375-10379.
26. Francoeur AM, Peebles CL, Gompper PT, Tan EM. Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity. J Immunol. 136:1986;1648-1653.
27. Zhang WW, Yaneva M. On the mechanisms of Ku protein binding to DNA. Biochem Biophys Res Commun. 186:1992;574-579.
28. Gottlieb TM, Jackson SP. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell. 72:1993;131-142.
29. cs) is molecularly cloned, and conceptual translation of the open reading frame reveals a PI3K-related phosphotransferase domain near the carboxyl terminus. Biochemical assays show that DNA-PK phosphorylates a restricted set of protein substrates, but has no detectable kinase activity toward phospholipids. This report provides strong support for the notion that the other members of the PI3K homolog family function as protein rather than lipid kinases in vivo.
30. Finnie NJ, Gottlieb TM, Blunt T, Jeggo P, Jackson SP. DNA-PK activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair. Proc Natl Acad Sci USA. 92:1995;320-324.
31. Jeggo PA, Taccioli GE, Jackson SP. Menage à trois - double strand break repair, V(D)J recombination and DNA-PK. of special interest Bioessays. 17:1995;949-957 This review focuses on the impact of DNA-PK deficiency on the development of the immune system and on cellular sensitivity to ionizing radiation.
32. Miller RD, Hogg J, Ozaki JH, Gell D, Jackson SP, Riblet R. Gene for the catalytic subunit of mouse DNA-dependent protein kinase maps to the scid locus. Proc Natl Acad Sci USA. 92:1995;10792-10795.
33. McKinnon PJ. Ataxia-telanglectasia: an inherited disorder of ionizing-radiation sensitivity in man: progress in the elucidation of the underlying biochemical defect. Hum Genet. 75:1987;197-208.
34. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, et al. A single ataxia telanglectasia gene with a product similar to PI-3 kinase. of outstanding interest Science. 268:1995;1749-1753 ATM, the gene mutated in the human autosomal recessive disorder AT, was identified by positional cloning on chromosome 11q22-23. ATM genomic sequences were used to isolate a partial cDNA clone designated AT 7-9. The predicted polypeptide encoded by AT 7-9 contains the PI3K homology domain near the carbonyl terminus. Immediately upstream of this domain is a region of lower but significant similarity to S. pombe rad3p, suggesting both a structural and functional convergence of human ATM with yeast proteins involved in monitoring the integrity of the genome.
35. Swift M, Chase CL, Morrell D. Cancer predisposition of ataxia-telanglectasia heterozygotes. Cancer Genet Cytogenet. 46:1990;21-27.
36. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telanglectasia. N Engl J Med. 325:1991;1831-1836.
37. Pandita TK, Pathak S, Geard C. Chromosome end associations, telomeres, and telomerase activity in ataxia telanglectasia. Cytogenet Cell Genet. 71:1995;86-93.
38. Rudolph NS, Latt SA. Flow cytophotometric analysis of X-ray sensitivity in ataxia telanglectasia. Mutat Res. 211:1989;31-41.
39. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace AJ Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telanglectasia. Cell. 71:1992;587-597.
40. Beamish H, Lavin MF. Radiosensitivity in ataxia-telanglectasia: anomalies in radiation-induced cell cycle delay. Int J Radiat Biol. 65:1994;175-184.
41. Davey MP, Bertness V, Nakahara K, Johnson JP, McBride OW, Waldman TA, Kirsh IK. Juxtaposition of the T-cell receptor alpha chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia telanglectasia. Proc Natl Acad Sci USA. 85:1988;9287-9291.
42. Russo G, Isobe M, Gatti R, Finan J, Batuman O, Hubner K, Nowell PC, Croce CM. Molecular analysis of a t(14;14)(q11;q32) chromosome translocation in T cells of an ataxia telanglectasia patient who developed T cell leukemia: a model of T cell leukmogenesis. Proc Natl Acad Sci USA. 86:1989;602-606.
43. Narducci MG, Virgilio L, Isobe M, Stoppacciaro A, Elli R, Fiorilli M, Carbonari M, Antonelli A, Chessa L, Croce CM, Russo G. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telanglectasia. of outstanding interest Blood. 86:1995;2358-2364 AT patients are prone to the development of T-cell leukemias. In these patients, clonal expansion of a preleukemic T-cell population often precedes the development of overt malignancy. The authors demonstrate in this study that preleukemic T cells from an AT patient overexpress the TCL1 protooncogene as a result of a translocation event involving the T-cell antigen receptor α-chain gene locus.
44. Abraham RT, Wiederrecht GJ. Immunopharmacology of rapamycin. of outstanding interest Annu Rev Immunol. 14:1996;483-510 This review provides a comprehensive summary of the pharmacology of rapamycin, and of the molecular and functional characterization of the protein targets of the FKBP12-rapamycin complex - the Tor proteins.
45. Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant repamycin in yeast. Science. 253:1991;905-909.
46. Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Rao MN, Hall M. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell. 73:1993;585-596.
47. Cafferkey R, Young P, McLaughlin M, Bergsma D, Koltin Y, Sathe G, Faucette L, Eng W-K, Johnson R, Livi G. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate repamycin cytotoxicity. Mol Cel Biol. 13:1993;6012-6023.
48. Helliwell S, Wagner P, Kunz J, Deuter-Reinhard M, Henriquez R, Hall M. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol Cell Biol. 5:1994;105-118.
49. Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL. A mammalian protein targeted by G1-arresting rapamycin - receptor complex. of outstanding interest Nature. 369:1994;756-758 The authors report the cloning of an FKBP - rapamycin-associated protein (FRAP) from a Jurkat cell cDNA library. The ability of structural analogs of rapamycin to bind FRAP when complexed to FKBP12 correlates with the potencies of these drugs as inhibitors of T-cell proliferation, suggesting that a functionally important target protein was isolated.
50. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. of outstanding interest Cell. 78:1994;35-43 This report describes the cloning of a rapamycin and FKBP12 target protein (RAFT1) from a rat brain cDNA library. RAFT1 is identical to the FRAP protein identified by Brown et al. [49].
51. Chiu MI, Katz H, Berlin V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. of outstanding interest Proc Natl Acad Sci USA. 91:1994;12574-12578 A yeast two-hybrid screen is used to isolate cDNAs encoding homologous rapamycin target proteins (RAPT1) from mouse and human cDNA libraries. Both RAPT1 cDNAs encode proteins identical to FRAP [49] and RAFT1 [50]. This report also defines a FKBP12-rapamycin-binding domain that lies immediately upstream of the carboxy-terminal PI3K related domain of RAPT1.
52. of special interest Sabers C, Martin M, Brunn G, Williams J, Dumont F, Wiederrecht G, Abraham R. Isolation of a protein target of the FKBP12 - rapamycin complex in mammalian cells. of special interest J Biol Chem. 270:1994;815-822 These investigators report the cloning of mTor, a mammalian homolog of the yeast Tor proteins. The amino acid sequence of mTor is identical to those of FRAP [49] and RAFT1 [50] and RAPT1 [51]. In addition, this study demonstrates that rapamycin resistance in T cells correlates with a decrease in the binding of mTor to the FKBP12-rapamycin complex. This result strongly suggests that interaction of the immunophilin drug complex with mTor is directly related to the immunosuppression action of rapamycin in vivo.
53. 1-phase progression.
54. Dumont F, Staruch M, Koprak S, Melino M, Sigal N. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol. 144:1990;251-258.
55. Bierer B, Mattila P, Standaert R, Herzenberg L, Burakoff S, Crabtree G, Schreiber S. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci USA. 87:1990;9231-9235.
56. cdc2 kinase activation in T lymphocytes. J Biol Chem. 268:1993;22737-22745.
57. Albers M, Williams R, Brown E, Tanaka A, Hall F, Schreiber S. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1 - cdk association in early G1 of an osteosarcoma cell line. J Biol Chem. 268:1993;22825-22829.
58. Sabatini DM, Pierchala BA, Barrow RK, Schell MJ, Snyder SH. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity. J Biol Chem. 270:1995;20875-20878.
59. Cardenas ME, Heitman J. FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity. EMBO J. 14:1995;5892-5907.
60. Brown EJ, Beal PA, Keith CT, Chen J, Shin TB, Schreiber SL. Control of p70 S6 kinase by kinase activity of FRAP in vivo. of special interest Nature. 377:1995;442-446 The authors employ a genetic approach to provide strong evidence that mTor lies upstream of p70 S6 kinase in Jurkat T-leukemic cells. The results further suggest that both an intact kinase domain and the amino-terminal region of mTor are required for activation of p70 S6 kinase in intact T cells.
61. Chung J, Kuo C, Crabtree G, Blenis J. Rapamycin-FKBP specifically blocks growth factor-dependent activation of and signaling by the 70 kD S6 protein kinases. Cell. 69:1992;1227-1236.
62. Price D, Grove J, Calvo V, Avuch J, Bierer B. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science. 257:1992;973-977.
63. Kuo C, Chung J, Fiorentino D, Flanagan W, Blenis J, Crabtree G. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 358:1992;70-73.
64. Calvo V, Crews C, Vik T, Bierer B. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc Natl Acad Sci USA. 89:1992;7571-7575.
65. Lin T-A, Kong X, Saltiel AR, Blackshear PJ, Lawrence JC Jr. Control of PHAS-I by insulin 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway. of special interest J Biol Chem. 270:1995;18531-18538 This paper shows that insulin stimulation induces the phosphorylation of PHAS-I via a rapamycin-sensitive signaling pathway in 3T3-L1 adipocytes. Phosphorylation of PHAS-I relieves a negative inhibitory constraint on eukaryotic initiation factor (eIF)-4E binding to mRNA cap sites, and thereby facilitates a rate-limiting step in the stimulation of protein synthesis by insulin and other growth factors. These results suggest that mTor is an upstream component of a pathway leading to eIF-4E-dependent translation initiation in mammalian cells.
66. 1 to S phase progression in mammalian cells.
67. Kipl.
68. Kip1.
69. Dulic V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Harper JW, Elledge SJ, Reed SI. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023.